Credit Suisse’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1
Closed 4490
2022
Q2
$0 Buy
+1
New +$9 ﹤0.01% 4556
2019
Q3
Sell
-1,000
Closed -$8K 4313
2019
Q2
$8K Buy
+1,000
New +$10.2K ﹤0.01% 4060
2018
Q2
Sell
-822
Closed -$37K 4200
2018
Q1
$37K Sell
822
-42
-5% -$2.11K ﹤0.01% 3904
2017
Q4
$40K Sell
864
-290
-25% -$15.4K ﹤0.01% 3918
2017
Q3
$72K Buy
1,154
+37
+3% +$2.17K ﹤0.01% 4127
2017
Q2
$71K Buy
1,117
+243
+28% +$13.5K ﹤0.01% 3754
2017
Q1
$65K Sell
874
-509
-37% -$56.7K ﹤0.01% 3724
2016
Q4
$206K Buy
+1,383
New +$245K ﹤0.01% 3801

Other funds holding NH

Credit Suisse's NH Position: Q3 2022 in Review

Credit Suisse sold out of NantHealth, Inc (NH) in Q3 2022, closing a stake of 1 share.

Credit Suisse first reported a position in NH in Q4 2016 and held it in 8 quarters. The position peaked at $206K in Q4 2016. 38 funds tracked by Wall St. Rank hold NH as of Q3 2022.

  • Credit Suisse reported no remaining NantHealth, Inc position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 1 NantHealth, Inc share in Q3 2022.
  • Credit Suisse first reported a position in NantHealth, Inc in Q4 2016 and held it in 8 quarters.
  • Credit Suisse's NantHealth, Inc position peaked at $206K in Q4 2016.
  • 38 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.